Literature DB >> 26471369

From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.

Natalie L Trevaskis1, Lisa M Kaminskas1, Christopher J H Porter1,2.   

Abstract

The lymphatic system serves an integral role in fluid homeostasis, lipid metabolism and immune control. In cancer, the lymph nodes that drain solid tumours are a primary site of metastasis, and recent studies have suggested intrinsic links between lymphatic function, lipid deposition, obesity and atherosclerosis. Advances in the current understanding of the role of the lymphatics in pathological change and immunity have driven the recognition that lymph-targeted delivery has the potential to transform disease treatment and vaccination. In addition, the design of lymphatic delivery systems has progressed from simple systems that rely on passive lymphatic access to sophisticated structures that use nanotechnology to mimic endogenous macromolecules and lipid conjugates that 'hitchhike' onto lipid transport processes. Here, we briefly summarize the lymphatic system in health and disease and the varying mechanisms of lymphatic entry and transport, as well as discussing examples of lymphatic delivery that have enhanced therapeutic utility. We also outline future challenges to effective lymph-directed therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26471369     DOI: 10.1038/nrd4608

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  273 in total

1.  Oral tolerance elicited in mice by beta-lactoglobulin entrapped in biodegradable microspheres.

Authors:  S Pecquet; E Leo; R Fritsché; A Pfeifer; P Couvreur; E Fattal
Journal:  Vaccine       Date:  2000-01-18       Impact factor: 3.641

2.  Biomimetic reassembled chylomicrons as novel association model for the prediction of lymphatic transportation of highly lipophilic drugs via the oral route.

Authors:  Yi Lu; Yiting Qiu; Jianping Qi; Meiqing Feng; Dianwen Ju; Wei Wu
Journal:  Int J Pharm       Date:  2015-02-11       Impact factor: 5.875

3.  Oral delivery of antigens in liposomes with some lipid compositions modulates oral tolerance to the antigens.

Authors:  Kazuyoshi Masuda; Kazutoshi Horie; Ryuji Suzuki; Takayoshi Yoshikawa; Koichiro Hirano
Journal:  Microbiol Immunol       Date:  2002       Impact factor: 1.955

4.  Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs.

Authors:  Arik Dahan; Amnon Hoffman
Journal:  Eur J Pharm Sci       Date:  2005-03       Impact factor: 4.384

5.  Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis.

Authors:  Marie Ballester; Chiara Nembrini; Neeraj Dhar; Alexandre de Titta; Cyntia de Piano; Miriella Pasquier; Eleonora Simeoni; André J van der Vlies; John D McKinney; Jeffrey A Hubbell; Melody A Swartz
Journal:  Vaccine       Date:  2011-07-23       Impact factor: 3.641

6.  Attenuation of transplant arteriosclerosis by oral feeding of major histocompatibility complex encoding chitosan-DNA nanoparticles.

Authors:  Katja Goldmann; Julia Hoffmann; Sebastian Eckl; Bernd M Spriewald; Stephan M Ensminger
Journal:  Transpl Immunol       Date:  2012-12-05       Impact factor: 1.708

7.  Pharmacokinetic model to describe the lymphatic absorption of r-metHu-leptin after subcutaneous injection to sheep.

Authors:  Danielle N McLennan; Christopher J H Porter; Glenn A Edwards; Maria Brumm; Steven W Martin; Susan A Charman
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

8.  Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate.

Authors:  Shuang Cai; Yumei Xie; Taryn R Bagby; Mark S Cohen; M Laird Forrest
Journal:  J Surg Res       Date:  2008-03-26       Impact factor: 2.192

9.  Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheres.

Authors:  Joshua J Reineke; Daniel Y Cho; Yu-Ting Dingle; A Peter Morello; Jules Jacob; Christopher G Thanos; Edith Mathiowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-06       Impact factor: 11.205

10.  Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions.

Authors:  Olga Schulz; Elin Jaensson; Emma K Persson; Xiaosun Liu; Tim Worbs; William W Agace; Oliver Pabst
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

View more
  113 in total

Review 1.  Lipid-Drug Conjugate for Enhancing Drug Delivery.

Authors:  Danielle Irby; Chengan Du; Feng Li
Journal:  Mol Pharm       Date:  2017-01-24       Impact factor: 4.939

2.  A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine.

Authors:  Mackenzie L Cottrell; Kuo H Yang; Heather M A Prince; Craig Sykes; Nicole White; Stephanie Malone; Evan S Dellon; Ryan D Madanick; Nicholas J Shaheen; Michael G Hudgens; Jacob Wulff; Kristine B Patterson; Julie A E Nelson; Angela D M Kashuba
Journal:  J Infect Dis       Date:  2016-02-24       Impact factor: 5.226

3.  Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models.

Authors:  Manal A Elsheikh; Yosra S R Elnaggar; Dina Y Otify; Ossama Y Abdallah
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

Review 4.  Biomaterials for vaccine-based cancer immunotherapy.

Authors:  Rui Zhang; Margaret M Billingsley; Michael J Mitchell
Journal:  J Control Release       Date:  2018-10-09       Impact factor: 9.776

5.  Next-Generation Noncompetitive Nanosystems Based on Gambogic Acid: In silico Identification of Transferrin Receptor Binding Sites, Regulatory Shelf Stability, and Their Preliminary Safety in Healthy Rodents.

Authors:  M Arora; R Ganugula; N Kumar; G Kaur; J-P Pellois; P Garg; M N V Ravi Kumar
Journal:  ACS Appl Bio Mater       Date:  2019-07-04

6.  Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity.

Authors:  Chunsong Yu; Myunggi An; Evan Jones; Haipeng Liu
Journal:  Pharm Res       Date:  2018-02-08       Impact factor: 4.200

7.  Lipophilicity in Drug Development: Too Much or Not Enough?

Authors:  Christel A S Bergström; Mehran Yazdanian
Journal:  AAPS J       Date:  2016-07-08       Impact factor: 4.009

Review 8.  Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.

Authors:  Abhijit A Date; Justin Hanes; Laura M Ensign
Journal:  J Control Release       Date:  2016-06-09       Impact factor: 9.776

Review 9.  Understanding the functions and relationships of the glymphatic system and meningeal lymphatics.

Authors:  Antoine Louveau; Benjamin A Plog; Salli Antila; Kari Alitalo; Maiken Nedergaard; Jonathan Kipnis
Journal:  J Clin Invest       Date:  2017-09-01       Impact factor: 14.808

10.  Mechanism-based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long-acting anti-HIV drug combination nanoparticle formulation.

Authors:  John C Kraft; Lisa A McConnachie; Josefin Koehn; Loren Kinman; Jianguo Sun; Ann C Collier; Carol Collins; Danny D Shen; Rodney J Y Ho
Journal:  J Control Release       Date:  2018-02-10       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.